Lyra Therapeutics, Inc. (LYRA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.3101 |
| Open | 0.3061 |
| Bid | 0.2944 x 500 |
| Ask | 0.3015 x 400 |
| Day's range | 0.2873 - 0.3061 |
| 52-week range | 0.2860 - 6.7900 |
| Volume | |
| Avg. volume | 3,399,804 |
| Market cap | 17.997M |
| Beta (5Y monthly) | 0.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Lyra Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Lyra Therapeutics ( NASDAQ:LYRA ) First Quarter 2024 Results Key Financial Results Net loss: US$22.5m (loss widened by...
- Zacks
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates
Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of -34.62% and 33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
Lyra Therapeutics (LYRA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.